Provided herein are compositions for preventing, ameliorating, and/or reducing tissue ischemia and/or tissue damage due to ischemia, increasing blood vessel diameter, blood flow and tissue perfusion in the presence of vascular disease including peripheral vascular disease, atherosclerotic vascular disease, coronary artery disease, stroke and influencing other conditions, by suppressing CD47 and/or blocking TSP1 and/or CD47 activity or interaction. Influencing the interaction of CD47-TSP1 in blood vessels allows for control of blood vessel diameter and blood flow, and permits modification of blood pressure and cardiac function. Under conditions of decreased blood flow, for instance through injury or atherosclerosis, blocking TSP1-CD47 interaction allows blood vessels to dilate and increases blood flow, tissue perfusion and tissue survival.

An active material useful in an oxidative dehydrogenation reactor system has an active phase, and a mixed metal oxide support phase. The active phase includes a transition metal oxide such as manganese oxide, which is reversibly oxidizable and/or reducible between oxidized and reduced states. The support phase includes a mixed metal oxide of a two or more IUPAC Group 2-14 elements. The active phase can also include a promoter such as Na-WO4 and/or a selectivity modifier such as Al or ceria. Also, a reactor including the active material in a reactor, a method of making the active material, and a method of using the active material in a regenerative reaction process.

An active material useful in an oxidative dehydrogenation reactor system has an active phase, and a mixed metal oxide support phase. The active phase includes a transition metal oxide such as manganese oxide, which is reversibly oxidizable and/or reducible between oxidized and reduced states. The support phase includes a mixed metal oxide of a two or more IUPAC Group 2-14 elements. The active phase can also include a promoter such as Na-WO4 and/or a selectivity modifier such as Al or ceria. Also, a reactor including the active material in a reactor, a method of making the active material, and a method of using the active material in a regenerative reaction process.

An exhaust gas-purifying catalyst of the present invention comprises a substrate, and one or more catalytic layers provided on the substrate, wherein at least one of the catalytic layers (i) contains a precious metal, alumina, and an acidic oxide element, (ii) has a correlation coefficient ρ.sub.Al,AE of 0.70 or more, and (iii) has a correlation coefficient ρ.sub.PM,AE of 0.70 or more.

An exhaust gas-purifying catalyst of the present invention comprises a substrate, and one or more catalytic layers provided on the substrate, wherein at least one of the catalytic layers (i) contains a precious metal, alumina, and an acidic oxide element, (ii) has a correlation coefficient ρ.sub.Al,AE of 0.70 or more, and (iii) has a correlation coefficient ρ.sub.PM,AE of 0.70 or more.

Described herein are methods for coating a substrate with a photocatalytic compound, and photocatalytic elements prepared by these methods.

Described herein are methods for coating a substrate with a photocatalytic compound, and photocatalytic elements prepared by these methods.

A system for decomposing contaminants, including volatile compounds (VOCs), with a visible-spectrum photocatalytic composition.

According to one or more embodiments described, a zeolite supported catalyst may be synthesized by a process that includes combining a colloidal mixture with a metal oxide support material to form a support precursor material, processing the support precursor material to form a support material, and impregnating the support material with one or more metals to form the zeolite supported catalyst. The colloidal mixture may include nano-sized zeolite crystals, and the nano-sized zeolite crystals may have an average size of less than 100 nm.

According to one or more embodiments described, a zeolite supported catalyst may be synthesized by a process that includes combining a colloidal mixture with a metal oxide support material to form a support precursor material, processing the support precursor material to form a support material, and impregnating the support material with one or more metals to form the zeolite supported catalyst. The colloidal mixture may include nano-sized zeolite crystals, and the nano-sized zeolite crystals may have an average size of less than 100 nm.